Filed before 2025Filed 6 January 2023
Xenter, Inc. has sold $19.6M so far
Xenter, Inc., a biotech company based in Draper, UT, has sold $19.6M so far in its debt round, according to a filing dated 6 January 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 6 January 2023
- First filed
- 14 July 2021
- Round
- Debt round (amended filing)
- Amount sold
- $19.6M
- Offering size
- $20M
- Investors so far
- 79
- Based in
- Draper, UT
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 78% of the 1,396 tracked raises with an amount filed in 2023, and than 60% of the 142 in biotech.
Xenter, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Jan 2023 | New filing | $1.13M | Another raise |
| 6 Jan 2023 | Amended filing | $19.6M | This raise |
| 14 Jul 2021 | New filing | $1M | This raise |
More with Kendall Capital on the board
- Noveome Biotherapeutics, Inc.$6.75M
- Rejuvenate Bio Inc$19.5M
- EpiBone, Inc.$4.29M
- VitaKey Inc.Undisclosed
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.